Michael Adam

2012

In 2012, Michael Adam earned a total compensation of $393.1K as Former Senior Vice President and Chief Operating Officer at Heron Therapeutics, a 86% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$73,700
Salary$312,000
Other$7,500
Total$393,050

Adam received $312K in salary, accounting for 79% of the total pay in 2012.

Adam also received $73.7K in non-equity incentive plan and $7.5K in other compensation.

Rankings

In 2012, Michael Adam's compensation ranked 9,433rd out of 11,487 executives tracked by ExecPay. In other words, Adam earned more than 17.9% of executives.

ClassificationRankingPercentile
All
9,433
out of 11,487
18th
Division
Manufacturing
3,486
out of 4,252
18th
Major group
Chemicals And Allied Products
960
out of 1,200
20th
Industry group
Drugs
719
out of 922
22nd
Industry
Pharmaceutical Preparations
553
out of 697
21st
Source: SEC filing on May 9, 2013.

Adam's colleagues

We found three more compensation records of executives who worked with Michael Adam at Heron Therapeutics in 2012.

2012

Robert Rosen

Heron Therapeutics

Former Senior Vice President and Chief Commercial Officer; current President

2012

Mark Gelder

Heron Therapeutics

Chief Medical Officer

2012

John Whelan

Heron Therapeutics

Chief Executive Officer

You may also like